{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:52:33Z","timestamp":1795053153105,"version":"4.10.2"},"reference-count":139,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1053\/j.ajkd.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T04:06:52Z","timestamp":1553141212000},"page":"437-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["KDOQI US Commentary on the 2017 ACC\/AHA Hypertension Guideline"],"prefix":"10.1053","volume":"73","author":[{"given":"Holly J.","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Beddhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2019.01.007_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"10022","key":"10.1053\/j.ajkd.2019.01.007_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1053\/j.ajkd.2019.01.007_bib3","first-page":"2103","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1053\/j.ajkd.2019.01.007_bib4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ndt\/gfw433","volume":"32","author":"Sarafidis","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"10.1053\/j.ajkd.2019.01.007_bib6","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib7","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib9","doi-asserted-by":"crossref","first-page":"e0171106","DOI":"10.1371\/journal.pone.0171106","article-title":"Comparison of urine dipstick and albumin:creatinine ratio for chronic kidney disease screening: a population-based study","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/fampra\/cms057","article-title":"Diagnostic accuracy of urine dipstick testing in screening for microalbuminuria in type 2 diabetes: a cohort study in primary care","volume":"30","author":"Nagrebetsky","year":"2013","journal-title":"Fam Pract"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic\u00a0and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00004872-200203000-00015","article-title":"Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study","volume":"20","author":"Wachtell","year":"2002","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney\u00a0Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","article-title":"Cost-effectiveness of primary screening for CKD: a systematic review","volume":"63","author":"Komenda","year":"2014","journal-title":"Am\u00a0J Kidney Dis"},{"issue":"23","key":"10.1053\/j.ajkd.2019.01.007_bib15","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1001\/jama.290.23.3101","article-title":"Screening for proteinuria in US adults: a cost-effectiveness analysis","volume":"290","author":"Boulware","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2009.11.017","article-title":"A\u00a0health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening","volume":"55","author":"Hoerger","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2019.01.007_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-156-8-201204170-00008","article-title":"Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians clinical practice guideline","volume":"156","author":"Fink","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"64","author":"Tuttle","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2019.01.007_bib19","article-title":"Standardization of urine albumin measurements: status and performance goals","author":"Miller","year":"2017","journal-title":"J\u00a0Appl Lab Med"},{"issue":"19","key":"10.1053\/j.ajkd.2019.01.007_bib20","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"9349","key":"10.1053\/j.ajkd.2019.01.007_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11906-013-0403-y","article-title":"Association between pre-hypertension and cardiovascular outcomes: a systematic review\u00a0and meta-analysis of prospective studies","volume":"15","author":"Guo","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.amjcard.2013.03.023","article-title":"Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease","volume":"112","author":"Shen","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamainternmed.2018.0310","article-title":"Incremental benefits and harms of the 2017 American College of Cardiology\/American Heart Association high blood pressure guideline","volume":"178","author":"Bell","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2017.10.073","article-title":"Potential U.S. population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"71","author":"Muntner","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2019.01.007_bib26","article-title":"Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement","volume":"163","author":"[No author listed]","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/jhh.2014.9","article-title":"Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions","volume":"28","author":"Peacock","year":"2014","journal-title":"J\u00a0Hum Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.amjhyper.2006.12.011","article-title":"Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage","volume":"20","author":"Shimbo","year":"2007","journal-title":"Am J Hypertens"},{"issue":"8288","key":"10.1053\/j.ajkd.2019.01.007_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(82)91163-1","article-title":"Error in blood-pressure measurement due to incorrect cuff size in obese patients","volume":"2","author":"Maxwell","year":"1982","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00126097-200006000-00002","article-title":"Optimizing cuff width for noninvasive measurement of blood pressure","volume":"5","author":"Marks","year":"2000","journal-title":"Blood Press Monit"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00126097-200306000-00002","article-title":"Effect of standard cuff on blood pressure readings in patients with obese arms. How frequent are arms of a 'large circumference'?","volume":"8","author":"Fonseca-Reyes","year":"2003","journal-title":"Blood Press Monit"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.amjcard.2010.03.040","article-title":"Comparison of automated oscillometric versus auscultatory blood pressure measurement","volume":"106","author":"Landgraf","year":"2010","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ajh.2011.208","article-title":"Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension","volume":"25","author":"Hermida","year":"2012","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.108.115154","article-title":"Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease","volume":"53","author":"Pogue","year":"2009","journal-title":"Hypertension"},{"issue":"7","key":"10.1053\/j.ajkd.2019.01.007_bib35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.ki.5000247","article-title":"Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease","volume":"69","author":"Agarwal","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.ajkd.2012.01.026","article-title":"Blood pressure measurement: clinic, home, ambulatory, and beyond","volume":"60","author":"Drawz","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib37","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/HJH.0000000000000995","article-title":"The association between home vs. ambulatory night-time blood pressure and end-organ damage in the general population","volume":"34","author":"Lindroos","year":"2016","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.110.160911","article-title":"Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis","volume":"57","author":"Agarwal","year":"2011","journal-title":"Hypertension"},{"issue":"13","key":"10.1053\/j.ajkd.2019.01.007_bib39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinternmed.2011.276","article-title":"Home blood pressure management and improved blood pressure control: results from a randomized controlled trial","volume":"171","author":"Bosworth","year":"2011","journal-title":"Arch Intern Med"},{"issue":"7515","key":"10.1053\/j.ajkd.2019.01.007_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bmj.38558.393669.E0","article-title":"Targets and self-monitoring in hypertension: randomised controlled trial and cost effectiveness analysis","volume":"331","author":"McManus","year":"2005","journal-title":"BMJ"},{"issue":"7458","key":"10.1053\/j.ajkd.2019.01.007_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.38121.684410.AE","article-title":"Blood pressure control by home monitoring: meta-analysis of randomised trials","volume":"329","author":"Cappuccio","year":"2004","journal-title":"BMJ"},{"issue":"9736","key":"10.1053\/j.ajkd.2019.01.007_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(10)60964-6","article-title":"Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial","volume":"376","author":"McManus","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/fampra\/cmp094","article-title":"A\u00a0primary care pragmatic cluster randomized trial of the use of home blood pressure monitoring on blood pressure levels in hypertensive patients with above target blood pressure","volume":"27","author":"Godwin","year":"2010","journal-title":"Fam Pract"},{"key":"10.1053\/j.ajkd.2019.01.007_bib44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2458-9-456","article-title":"The effectiveness of health coaching, home blood pressure monitoring, and home-titration in controlling hypertension among low-income patients: protocol for a randomized controlled trial","volume":"9","author":"Bennett","year":"2009","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.ki.5000081","article-title":"Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease","volume":"69","author":"Agarwal","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ajh.2011.100","article-title":"Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies","volume":"24","author":"Omboni","year":"2011","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib47","doi-asserted-by":"crossref","first-page":"e0155677","DOI":"10.1371\/journal.pone.0155677","article-title":"How accurate are home blood pressure devices in use? A cross-sectional study","volume":"11","author":"Ruzicka","year":"2016","journal-title":"PLoS One"},{"issue":"19","key":"10.1053\/j.ajkd.2019.01.007_bib48","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jacc.2016.08.035","article-title":"The cardiovascular risk of white-coat hypertension","volume":"68","author":"Franklin","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1053\/j.ajkd.2019.01.007_bib49","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/HJH.0b013e3282ef6185","article-title":"Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis","volume":"25","author":"Fagard","year":"2007","journal-title":"J\u00a0Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2215\/CJN.08530815","article-title":"Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"10.1053\/j.ajkd.2019.01.007_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1712231","article-title":"Relationship between clinic and ambulatory blood-pressure measurements and mortality","volume":"378","author":"Banegas","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2215\/CJN.05391008","article-title":"Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis","volume":"4","author":"Bangash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib53","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.ajkd.2019.01.007_bib54","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2215\/CJN.10491015","article-title":"Effects of stenting for atherosclerotic renal artery stenosis on eGFR and predictors of clinical events in the CORAL trial","volume":"11","author":"Tuttle","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.007_bib55","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization versus medical therapy for renal-artery stenosis","volume":"361","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajh\/hpu147","article-title":"Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea: a randomized controlled trial","volume":"28","author":"Huang","year":"2015","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10641963.2016.1148156","article-title":"Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials","volume":"38","author":"Feldstein","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"10.1053\/j.ajkd.2019.01.007_bib58","article-title":"Rationale and methodology of the SARAH trial: long-term cardiovascular outcomes in patients with resistant hypertension and obstructive sleep apnea","author":"Sapina-Beltran","year":"2018","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib59","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jch.12789","article-title":"Controversies surrounding renal denervation: lessons learned from real-world experience in two United Kingdom centers","volume":"18","author":"Burchell","year":"2016","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","article-title":"Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: report from the Chronic Renal Insufficiency Cohort Study","volume":"67","author":"Thomas","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/jhh.2014.64","article-title":"Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis","volume":"29","author":"Liu","year":"2015","journal-title":"J\u00a0Hum Hypertens"},{"issue":"10008","key":"10.1053\/j.ajkd.2019.01.007_bib63","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib64","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"10108","key":"10.1053\/j.ajkd.2019.01.007_bib65","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","journal-title":"Lancet"},{"issue":"10137","key":"10.1053\/j.ajkd.2019.01.007_bib66","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1053\/j.ajkd.2019.01.007_bib67","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A\u00a0clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group","volume":"336","author":"Appel","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1053\/j.ajkd.2019.01.007_bib68","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib69","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.ajkd.2016.05.019","article-title":"DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease","volume":"68","author":"Rebholz","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib70","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2008.10.048","article-title":"The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) trial","volume":"53","author":"Jacobs","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"35","key":"10.1053\/j.ajkd.2019.01.007_bib71","first-page":"1125","article-title":"State-specific trends in fruit and vegetable consumption among adults --- United States, 2000-2009","volume":"59","year":"2010","journal-title":"MMWR Morbid Mort Wkly Rep"},{"issue":"45","key":"10.1053\/j.ajkd.2019.01.007_bib72","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.15585\/mmwr.mm6645a1","article-title":"Disparities in state-specific adult fruit and vegetable consumption - United States, 2015","volume":"66","author":"Lee-Kwan","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib73","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib74","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1053\/j.ajkd.2019.01.007_bib75","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"25, pt B","key":"10.1053\/j.ajkd.2019.01.007_bib76","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1053\/j.ajkd.2019.01.007_bib77","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in\u00a0type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2019.01.007_bib78","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jash.2017.05.001","article-title":"Comparative efficacy of \u03b2-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis","volume":"11","author":"Zhang","year":"2017","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib79","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1161\/HYP.0000000000000067","volume":"71","author":"Reboussin","year":"2018","journal-title":"Hypertension"},{"issue":"20","key":"10.1053\/j.ajkd.2019.01.007_bib80","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1053\/j.ajkd.2019.01.007_bib81","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1053\/j.ajkd.2019.01.007_bib82","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11906-014-0525-x","article-title":"Thiazide diuretics in chronic kidney disease","volume":"17","author":"Sinha","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"10.1053\/j.ajkd.2019.01.007_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000358603","article-title":"Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study","volume":"4","author":"Agarwal","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.007_bib85","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2019.01.007_bib86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","article-title":"Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure","volume":"26","author":"Knauf","year":"1995","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1053\/j.ajkd.2019.01.007_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A\u00a0randomized trial of furosemide vs. hydrochlorothiazide in patients with chronic renal failure and hypertension","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2019.01.007_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","article-title":"A\u00a0pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease","volume":"14","author":"Dussol","year":"2012","journal-title":"J\u00a0Clin Hypertens"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib89","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.ajkd.2019.01.007_bib90","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjhyper.2004.06.001","article-title":"Racial\/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"17","author":"Kramer","year":"2004","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD","volume":"62","author":"Taler","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.ajkd.2019.01.007_bib93","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archinte.168.8.832","article-title":"Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans","volume":"168","author":"Appel","year":"2008","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1053\/j.ajkd.2019.01.007_bib94","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"9463","key":"10.1053\/j.ajkd.2019.01.007_bib95","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"10017","key":"10.1053\/j.ajkd.2019.01.007_bib96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic\u00a0review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"20","key":"10.1053\/j.ajkd.2019.01.007_bib97","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of\u00a0angiotensin-converting-enzyme inhibition on diabetic nephropathy. the Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"9176","key":"10.1053\/j.ajkd.2019.01.007_bib98","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2019.01.007_bib99","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomized placebo controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.114.04334","article-title":"Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the Chronic Renal Insufficiency Cohort Study","volume":"65","author":"Bansal","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ajkd.2016.12.020","article-title":"Blood pressure before initiation of maintenance dialysis and subsequent mortality","volume":"70","author":"Sumida","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-159-4-201308200-00004","article-title":"Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study","volume":"159","author":"Kovesdy","year":"2013","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib103","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.ajkd.2010.10.048","article-title":"Hypertension after kidney transplant","volume":"57","author":"Mangray","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1053\/j.ajkd.2019.01.007_bib105","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/0929867323666151221150052","article-title":"The role of immunosuppressive medications in the pathogenesis of hypertension and efficacy and safety of antihypertensive agents in kidney transplant recipients","volume":"23","author":"Divac","year":"2016","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib106","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2016.12.017","article-title":"Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial","volume":"69","author":"Moes","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib107","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib108","first-page":"1142","article-title":"Intensive blood pressure lowering in patients with and patients without type 2 diabetes: a pooled analysis from two randomized trials","volume":"41","author":"Brouwer","year":"2018","journal-title":"Diabetes\u00a0Care"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08037051.2014.946787","article-title":"Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson memorial lecture","volume":"24","author":"Kjeldsen","year":"2015","journal-title":"Blood Press"},{"issue":"11","key":"10.1053\/j.ajkd.2019.01.007_bib110","article-title":"Systolic blood pressure response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): a possible explanation for discordant trial results","volume":"6","author":"Huang","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1053\/j.ajkd.2019.01.007_bib111","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/dc17-1366","article-title":"Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP","volume":"40","author":"Buckley","year":"2017","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1053\/j.ajkd.2019.01.007_bib112","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMe1513301","article-title":"Redefining blood-pressure targets--SPRINT starts the marathon","volume":"373","author":"Perkovic","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2019.01.007_bib113","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009326","article-title":"Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in persons with type 2 diabetes on standard glycemic control and in persons without diabetes: reconciling results from ACCORD BP and SPRINT","author":"Beddhu","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1053\/j.ajkd.2019.01.007_bib114","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American Diabetes Association","volume":"40","author":"de Boer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2019.01.007_bib115","first-page":"259","article-title":"KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"18","key":"10.1053\/j.ajkd.2019.01.007_bib116","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.jacc.2016.02.055","article-title":"Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population","volume":"67","author":"Rana","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1053\/j.ajkd.2019.01.007_bib117","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >\/=75 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2019.01.007_bib118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib119","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.ajkd.2017.08.021","article-title":"Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"71","author":"Rocco","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ki.2009.469","article-title":"Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"77","author":"Levin","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib121","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ki.2012.136","article-title":"Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"82","author":"Robinson","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.007_bib122","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","article-title":"\u201cU\u201d curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc","volume":"54","author":"Zager","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib123","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0272-6386(99)70188-5","article-title":"Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients","volume":"33","author":"Port","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"4 suppl 3","key":"10.1053\/j.ajkd.2019.01.007_bib124","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2215\/CJN.01891105","article-title":"Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure","volume":"1","author":"Agarwal","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.007_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib127","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2215\/CJN.02250507","article-title":"Home blood pressures are of greater prognostic value than hemodialysis unit recordings","volume":"2","author":"Alborzi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.HYP.0000196279.29758.f4","article-title":"Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy","volume":"47","author":"Agarwal","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.007_bib129","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.109.144899","article-title":"Blood pressure and mortality among hemodialysis patients","volume":"55","author":"Agarwal","year":"2010","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib130","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1046\/j.1523-1755.2000.00107.x","article-title":"Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients","volume":"57","author":"Amar","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.007_bib131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1681\/ASN.2017020135","article-title":"BP in dialysis: results of a pilot study","volume":"29","author":"Miskulin","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.01.007_bib132","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2019.01.007_bib133","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"7160","key":"10.1053\/j.ajkd.2019.01.007_bib134","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.007_bib135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.007_bib136","first-page":"569","article-title":"Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.ajkd.2019.01.007_bib137","unstructured":"Hiddo J, Heerspink L, Ninomiya T, Huxley R, Perkovic V. Kidney Health Australia-caring for Australians with renal impairment. Cardiovascular effects of blood pressure lowering in patients with chronic kidney disease. 2013. http:\/\/www.cari.org.au\/CKD\/CKD%20cardiovascular%20disease\/Blood_pressure_May_2013_final.pdf. Accessed May 15, 2018."},{"issue":"10","key":"10.1053\/j.ajkd.2019.01.007_bib138","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","volume":"31","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1053\/j.ajkd.2019.01.007_bib139","unstructured":"Department of Veterans Affairs\/Department of Defense. VA\/DoD Clinical practice guideline for the diagnosis and management of hypertension. Version 3.0. 2014. Washington, DC. https:\/\/www.healthquality.va.gov\/guidelines\/CD\/htn\/VADoDCPGHTN2014.pdf. Accessed May 1,\u00a02018."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619300393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619300393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:19:33Z","timestamp":1759461573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619300393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0272638619300393"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.007","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDOQI US Commentary on the 2017 ACC\/AHA Hypertension Guideline","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}